| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 53.74▲ | 53.36▲ | 53.14▲ | 45.27▲ | 47.49▲ |
| MA10 | 53.84▼ | 52.63▲ | 49.76▲ | 44.74▲ | 46.57▲ |
| MA20 | 53.68▲ | 49.05▲ | 46.35▲ | 46.33▲ | 44.87▲ |
| MA50 | 52.83▲ | 45.42▲ | 44.42▲ | 46.04▲ | 38.49▲ |
| MA100 | 50.19▲ | 44.44▲ | 45.35▲ | 44.13▲ | 30.35▲ |
| MA200 | 46.62▲ | 45.53▲ | 46.10▲ | 40.02▲ | 22.74▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.076▼ | 0.329▲ | 1.069▲ | 0.314▲ | 0.004▲ |
| RSI | 57.080▲ | 83.921▲ | 87.026▲ | 72.607▲ | 67.745▲ |
| STOCH | 54.497 | 92.286▲ | 94.891▲ | 35.179 | 62.791 |
| WILL %R | -41.176 | -3.204▲ | -3.034▲ | -2.983▲ | -2.899▲ |
| CCI | 34.997 | 94.192 | 89.895 | 195.240▲ | 227.491▲ |
| ▲ PSAR&MOM | $KNSA PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&MACD | $KNSA MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $KNSA RSI Cross Up and Volume | Set Alert |
| ▲ RSI | $KNSA RSI(14) Crossed Above 70 | Set Alert |
| RSI | $KNSA RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $KNSA MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $KNSA Price Crossed Above MA(50) | Set Alert |
| MA | $KNSA Price Crossed Above MA(26) | Set Alert |
| MA | $KNSA Price Crossed Above MA(13) | Set Alert |
| ▲ GAP | $KNSA Open Gap Up %5 | Set Alert |
| ▲ GAP | $KNSA Open Gap Up %3 | Set Alert |
| ▲ GAP | $KNSA Open Gap Up %2 | Set Alert |
| ▲ BREAK | $KNSA Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $KNSA Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $KNSA Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $KNSA Price Breaks 10 Days High | Set Alert |
|
Tuesday, April 28, 2026 05:10 PM
The biotech delivered a beat-and-raise first quarter.
|
|
Tuesday, April 28, 2026 10:14 AM
Kiniksa Pharmaceuticals shows strong earnings momentum, drawing attention in biotech space with improving fundamentals and steady institutional participation.
|
|
Tuesday, April 28, 2026 09:43 AM
Kiniksa Pharma (KNSA) stock hit a 52-week high as the company reported better-than-expected Q1 2026 thanks to Regeneron (REGN)-partnered Arcalyst. Read more here.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/04/26 | 46.71 | 54.23 | 45.01 | 53.85 | 3,001,990 |
| 27/04/26 | 42.67 | 44.195 | 42.61 | 43.61 | 906,464 |
| 24/04/26 | 42.62 | 43.00 | 41.945 | 42.79 | 569,903 |
| 23/04/26 | 43.30 | 43.84 | 42.51 | 43.05 | 563,435 |
| 22/04/26 | 42.84 | 43.69 | 42.67 | 43.04 | 687,013 |
| 21/04/26 | 42.16 | 43.46 | 41.49 | 42.45 | 1,074,361 |
| 20/04/26 | 44.77 | 44.86 | 42.46 | 42.46 | 1,157,823 |
| 17/04/26 | 45.40 | 45.91 | 44.74 | 44.90 | 995,136 |
| 16/04/26 | 46.44 | 46.62 | 44.90 | 45.32 | 587,181 |
| 15/04/26 | 47.00 | 47.555 | 45.21 | 45.89 | 701,734 |
|
|
||||
|
|
||||
|
|